Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial - Yu, L M; Bafadhel, M; Dorward, J (Lancet, 2021)
et al.